Shatnawi Aymen, Latif David A
Department of Pharmaceutical and Administrative Sciences, University of Charleston School of Pharmacy, Charleston, West Virginia, USA.
J Eval Clin Pract. 2017 Jun;23(3):586-592. doi: 10.1111/jep.12677. Epub 2016 Nov 24.
The role of pharmacists in chronic disease state management has been shown to significantly improve patient health outcomes and reduce overall health care costs. The current study is designed to assess the roles and attitudes of West Virginia (WV) pharmacists toward diabetes, evaluate services provided, address pharmacist clinical understanding and training, and demonstrate the challenges that limit pharmacists ability to deliver an efficient disease state management.
We invited 435 preceptors affiliated with the University of Charleston School of Pharmacy to participate in the study using Qualtrics online survey software. The survey was divided into sections related to pharmacists, practice environment, pharmacist's roles in diabetes management, and challenges faced that limit their ability to deliver effective care to diabetic patients. Data were analyzed using 1-way analysis of variance, and a P value ≤.05 was considered statistically significant.
Of all eligible invited preceptors, 104 accessed the online survey based on the Qualtrics tracking tool, while 58 participated in the survey with a 56% response rate. Generally, WV pharmacists have positive attitudes regarding the provision of primary activities related to drug use and its associated problems. However, we report that WV pharmacists are less involved in providing education or recommendations regarding diabetes-associated risk factors such as nephropathy, retinopathy, foot care, and gastroparesis. In addition, the majority of pharmacists indicated that they face many challenges related to patient and the practice site environment that limit their ability to provide optimum diabetes patient care services.
Despite the mounting evidence that pharmacists can improve diabetic patient outcomes while significantly reducing overall costs, WV pharmacists are less involved in providing education or counseling in a variety of areas related to disease state management. In addition, identifying pharmacist challenges provides significant information for future planning toward improving diabetic patient care.
药剂师在慢性病管理中的作用已被证明能显著改善患者健康状况并降低总体医疗成本。本研究旨在评估西弗吉尼亚州(WV)药剂师对糖尿病的作用和态度,评估所提供的服务,了解药剂师的临床知识和培训情况,并揭示限制药剂师提供高效疾病管理能力的挑战。
我们邀请了435名与查尔斯顿大学药学院有关联的带教老师,使用Qualtrics在线调查软件参与研究。调查分为与药剂师、执业环境、药剂师在糖尿病管理中的作用以及限制他们为糖尿病患者提供有效护理能力所面临的挑战相关的几个部分。数据采用单因素方差分析进行分析,P值≤.05被认为具有统计学意义。
在所有符合条件被邀请的带教老师中,根据Qualtrics跟踪工具,有104人访问了在线调查,其中58人参与了调查,回复率为56%。总体而言,WV药剂师对提供与药物使用及其相关问题有关的主要活动持积极态度。然而,我们发现WV药剂师较少参与提供与糖尿病相关危险因素(如肾病、视网膜病变、足部护理和胃轻瘫)有关的教育或建议。此外,大多数药剂师表示,他们面临着许多与患者和执业场所环境相关的挑战,这些挑战限制了他们提供最佳糖尿病患者护理服务的能力。
尽管越来越多的证据表明药剂师可以改善糖尿病患者的病情,同时显著降低总体成本,但WV药剂师较少参与提供与疾病管理相关的多个领域的教育或咨询服务。此外,识别药剂师面临的挑战为未来改善糖尿病患者护理的规划提供了重要信息。